These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 27997745)
1. Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Miller ET; Chamie K; Kwan L; Lewis MS; Knudsen BS; Garraway IP Cancer Med; 2017 Jan; 6(1):163-172. PubMed ID: 27997745 [TBL] [Abstract][Full Text] [Related]
2. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database. Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083 [TBL] [Abstract][Full Text] [Related]
3. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer. Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880 [TBL] [Abstract][Full Text] [Related]
4. First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH. Griffin K; Csizmadi I; Howard LE; Pomann GM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Beebe-Dimmer J; Freedland SJ Cancer Causes Control; 2019 Mar; 30(3):259-269. PubMed ID: 30701374 [TBL] [Abstract][Full Text] [Related]
5. Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database. Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ Eur Urol; 2014 Mar; 65(3):620-7. PubMed ID: 23245686 [TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer. Jang TL; Patel N; Faiena I; Radadia KD; Moore DF; Elsamra SE; Singer EA; Stein MN; Eastham JA; Scardino PT; Lin Y; Kim IY; Lu-Yao GL Cancer; 2018 Oct; 124(20):4010-4022. PubMed ID: 30252932 [TBL] [Abstract][Full Text] [Related]
7. Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy? Vidal AC; Howard LE; De Hoedt A; Kane CJ; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Lechpammer S; Flanders SC; Freedland SJ Cancer; 2019 Feb; 125(3):434-441. PubMed ID: 30427535 [TBL] [Abstract][Full Text] [Related]
8. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800 [TBL] [Abstract][Full Text] [Related]
9. Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality. Tilki D; Chen MH; Wu J; Huland H; Graefen M; Braccioforte M; Moran BJ; D'Amico AV JAMA Oncol; 2019 Feb; 5(2):213-220. PubMed ID: 30452521 [TBL] [Abstract][Full Text] [Related]
10. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort. Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160 [TBL] [Abstract][Full Text] [Related]
11. Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy. Ahn HK; Lee KS; Kim D; Rha KH; Hong SJ; Chung BH; Koo KC Yonsei Med J; 2020 Aug; 61(8):652-659. PubMed ID: 32734728 [TBL] [Abstract][Full Text] [Related]
12. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy. Kelkar S; Oyekunle T; Eisenberg A; Howard L; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen Z; Terris MK; Freedland SJ; Csizmadi I JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34169227 [TBL] [Abstract][Full Text] [Related]
13. [Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy]. Ji GJ; Huang C; Song G; Li XS; Song Y; Zhou LQ Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):657-662. PubMed ID: 28816284 [TBL] [Abstract][Full Text] [Related]
14. Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer. Howard LE; Moreira DM; De Hoedt A; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ BJU Int; 2017 Nov; 120(5B):E80-E86. PubMed ID: 28371163 [TBL] [Abstract][Full Text] [Related]
15. The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer. Choi SY; Lim B; Chi BH; Lee W; Kim JH; Kyung YS; You D; Kim CS Medicine (Baltimore); 2021 Aug; 100(31):e26833. PubMed ID: 34397848 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit. Gupta M; Patel HD; Schwen ZR; Tran PT; Partin AW BJU Int; 2019 Feb; 123(2):252-260. PubMed ID: 29626845 [TBL] [Abstract][Full Text] [Related]
17. Greatest percentage of involved core length and the risk of death from prostate cancer in men with highest Gleason score ≥ 7. Cheney MD; Chen MH; Zhang D; Phillips JG; Loffredo MJ; D'Amico AV Clin Genitourin Cancer; 2014 Aug; 12(4):234-40. PubMed ID: 24594503 [TBL] [Abstract][Full Text] [Related]
18. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865 [TBL] [Abstract][Full Text] [Related]
19. Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer. Sarkar RR; Bryant AK; Parsons JK; Ryan ST; Karim Kader A; Kane CJ; McKay RR; Sandhu A; Murphy JD; Rose BS Eur Urol Oncol; 2019 Sep; 2(5):584-588. PubMed ID: 31411995 [TBL] [Abstract][Full Text] [Related]
20. Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy. Tendulkar RD; Reddy CA; Stephans KL; Ciezki JP; Klein EA; Mahadevan A; Kupelian PA Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1397-404. PubMed ID: 21665379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]